Sei Investments CO Macrogenics Inc Transaction History

Sei Investments CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 06, 2020	SELL	$24.69 - $31.6 $585,844 - $749,804	-23,728 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$5.2 - $29.12 $123,385 - $690,959	23,728 New	23,728 $662,000
Q4 2019 Feb 06, 2020	SELL	$7.95 - $12.27 $322,070 - $497,082	-40,512 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $30,485 - $41,410	-2,101 Reduced 4.93%	40,512 $687,000
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $473,430 - $1.09 Million	42,613 New	42,613 $766,000

134

55.5M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.